SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-23-063297
Filing Date
2023-05-23
Accepted
2023-05-22 21:06:34
Documents
3
Effectiveness Date
2023-05-23

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2316328d1_s8pos.htm S-8 POS 33571
2 EXHIBIT 4.4 tm2316328d1_ex4-4.htm EX-4.4 58876
3 EXHIBIT 4.5 tm2316328d1_ex4-5.htm EX-4.5 66204
  Complete submission text file 0001104659-23-063297.txt   159888
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-222043-01 | Film No.: 23946324
SIC: 2834 Pharmaceutical Preparations